News

Filter

Current filters:

Men's Health

1 to 9 of 74 results

Endo to divest its American Medical Systems men's and prostate businesses to Boston Scientific

Endo to divest its American Medical Systems men's and prostate businesses to Boston Scientific

03-03-2015

Ireland-headquartered Endo International has entered into a definitive agreement with Boston Scientific…

EndoLicensingMen's HealthPharmaceuticalUSA

SOBI granted marketing authorization for Xiapex in Peyronie's disease in the EU

SOBI granted marketing authorization for Xiapex in Peyronie's disease in the EU

02-02-2015

Nordic biotech firm Swedish Orphan Biovitrum (STO: SOBI) has received approval from the European Commission…

Men's HealthPharmaceuticalRegulationSobiXiaflexXiapex

Sophiris Bio shares slide on Phase III results of PRX302

Sophiris Bio shares slide on Phase III results of PRX302

16-12-2014

Biotech company Sophiris Bio saw shares in the company fall up to almost 80% following an announcement…

BiotechnologyMen's HealthPRX302ResearchSophiris Bio

Erectile dysfunction and diabetes drugs to be tested as dementia treatments

Erectile dysfunction and diabetes drugs to be tested as dementia treatments

12-12-2014

The Alzheimer's Drug Discovery Foundation (ADDF) and the Alzheimer's Society UK announced new funding…

CialisDiabetesEli LillyliraglutideMen's HealthNeurologicalNovo NordiskPharmaceuticalResearchTadalafilVictoza

Trimel and Endo agree on Natesto manufacturing and marketing collaboration

Trimel and Endo agree on Natesto manufacturing and marketing collaboration

24-11-2014

Trimel Biopharma, a subsidiary of Canada's Trimel Pharmaceuticals Corp, has signed an agreement with…

CanadaEndoLicensingMarkets & MarketingMen's HealthPharmaceuticalTrimel PharmaceuticalsUSA

Nymox plunges as NX1207 fails Ph III endpoints

03-11-2014

Canada-based biotech firm Nymox Pharmaceutical saw its shares decimated in pre-market trading after it…

BiotechnologyMen's HealthNX1207Nymox PharmaRecordatiResearch

Forendo licenses fispemifene to Apricus in USA

20-10-2014

Finland-based Forendo Pharma, a Swedish firm Karolinska Development portfolio company, has entered into…

Apricus BiosciencesfispemifeneForendo PharmaGenito-urinaryKarolinska DevelopmentLicensingMen's HealthPharmaceuticalUSA

Endo’s buy of struggling Auxilium for $2.6 billion analysed by GlobalData

12-10-2014

Endo International’s $2.6 billion purchase of Auxilium Pharmaceuticals (The Pharma Letter October 9)…

Auxilium PharmaceuticalsEndo InternationalMen's HealthMergers & AcquisitionsPharmaceuticalRare diseasesTestimTestopelXiaflex

1 to 9 of 74 results

Back to top